Difference between revisions of "MRE Biomarker Ctte"
Jump to navigation
Jump to search
| Line 26: | Line 26: | ||
*[[Media:MRE-QIBA_Profile-2019-06-06-CONSENSUS-maintenance.pdf | MR Elastography of the Liver Consensus Profile: Maintenance draft (2019-06-06)]] | *[[Media:MRE-QIBA_Profile-2019-06-06-CONSENSUS-maintenance.pdf | MR Elastography of the Liver Consensus Profile: Maintenance draft (2019-06-06)]] | ||
| − | *[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf|'''MRE Profile | + | *[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf|'''MRE Public Comment Profile: July 28, 2017''']] |
*[[Media:Draft-MRE-QIBAProfile-2017-07-06.pdf|''MRE Profile, Initial Draft: July 6, 2017'']] | *[[Media:Draft-MRE-QIBAProfile-2017-07-06.pdf|''MRE Profile, Initial Draft: July 6, 2017'']] | ||
Revision as of 16:23, 6 April 2021
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings
Approved call summaries:
Note: The last meeting of this group was held on March 15, 2021; notes are posted after they are approved by the MRE BC during the following t-con
MRE Profile Development
- MR Elastography of the Liver Consensus Profile: Maintenance draft (2019-06-06)
- MRE Public Comment Profile: July 28, 2017
- MRE Profile, Initial Draft: July 6, 2017